QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced PanelsBusiness Wire • 05/16/22
QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated PCR SystemBusiness Wire • 05/05/22
QIAGEN N.V. (QGEN) CEO Thierry Bernard on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/28/22
QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID products and increases full-year outlookBusiness Wire • 04/26/22
QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TBBusiness Wire • 03/24/22
Element Biosciences Partners with QIAGEN to Validate a Selection of QIAseq Targeted Library Construction Chemistries on Element's AVITI™ SystemBusiness Wire • 02/22/22
QIAGEN N.V. (QGEN) CEO Thierry Bernard on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/09/22
Qiagen Q4 Earnings Beat Expectations On High Demand For COVID-19 Tests, Issues FY22 GuidanceBenzinga • 02/09/22
QIAGEN beats outlook for fourth quarter and full-year 2021, delivers 22% CER full-year sales growth from non-COVID productsBusiness Wire • 02/08/22
QIAGEN's New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO RecommendationBusiness Wire • 02/07/22
QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 SurveillanceBusiness Wire • 01/25/22